Lv41
730 积分 2025-08-11 加入
Claudin-18 isoform 2-specific CAR T-cell therapy(satri-cel)versus treatment of physician's choice forpreviously treated advanced gastric or gastro-oesophageal junction cancer(CTo41-ST-01): arandomised,open-label, phase 2 trial
1个月前
已完结
Cold and hot tumors: from molecular mechanisms to targeted therapy
1个月前
已完结
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已关闭
Neoadjuvant immunotherapy for resectable hepatocellular carcinoma: a systematic review and meta-analysis
2个月前
已完结
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
2个月前
已完结
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 tria
2个月前
已完结
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus
2个月前
已完结
肝细胞癌合并门静脉癌栓手术治疗的应用进展
2个月前
已完结
TACE联合酪氨酸激酶抑制剂和免疫检查点抑制剂治疗肝细胞癌伴Vp1-Vp3型门静脉癌栓的临床研究
2个月前
已完结
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
2个月前
已完结
皖公网安备34019202002308
